News and Announcements
Leaf Resources July 2016 Update: JV with Claeris, Edison Research Report Released, Investor Presentation
- Published July 28, 2016 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Leaf Resources features as a Spec Buy in The Australian
The renewables play has won US backing that is bigger than Texas: a JV with Dallas-based renewables giant Claeris to develop Leaf’s homegrown process that converts biomass into cellulosic sugars…read more>>
Edison Research Report Released
Claeris JV to accelerate GlycellTM commercialistion
Leaf Resources has entered into agreements with US-based Claeris,LLC to establish a JV entity, Leaf Development, to develop up to five renewable chemical projects. Read the full report here>>
Investor Presentation
New investor presentation released….click here>>
Leaf in the News
Following the release of Leaf Resources silica announcement, we have received some media coverage
June 2016
- Business Environment Network -Turing Rice Husks into Silica
- The Australian – Leaf Turns food scraps into Silica
- Australian Mining -Sustainable silica extraction process patent lodged
- Morning Star
Oceans to hold more plastic than fish by 2050?
Ellen MacArther report says there will be more plastic than fish in the sea
As reported by The Guardian earlier this year, the Ellen MacArthur report highlights that new plastics will consume 20% of all oil production within 35 years, up from an estimated 5% today…read more>>
Company Updates
The System’s Immune System: Why Big Tech Will Solve What Big Pharma Can’t
The central investment thesis for the future of human health pits Big Pharma against Big Tech. This blog post explores the “Protocol Paradox” in current cancer care and argues that the convergence of hyperscalers and life-science experts—treating biology as a data and compute problem—represents the defining compounding investment opportunity of this era.
The Life Sciences Supercycle: Why Australian Biotech is Finally Delivering Billion-Dollar Outcomes
Australia’s life sciences sector is experiencing an unprecedented “Supercycle,” finally commercializing world-class research into global, billion-dollar businesses. Learn about the ASX heavyweights, the key drivers (AI, institutional execution, FDA pathway), and the investment opportunity at Emergence 2026.
Following the Billions: Where the Hyperscalers are Betting on the Future
The roadmap for the next decade isn’t hidden in pitch decks—it’s written on the balance sheets of Microsoft, Amazon, and Google. Their collective investment is flowing into three key areas: GPU Chips, AI Factories, and Energy. This foundational buildout signals a $7–$20 trillion economic convergence, where the physical race for infrastructure and energy is paramount. The article also covers the powerful macro case for digital assets in this new era.
Backed By Leading Investment Groups and Family Offices
